Skip to main content
. 2016 Sep 12;3(4):162–168. doi: 10.1016/j.ijpam.2016.08.008

Table 2.

Clinical characteristics of children.

Dose 1 g/m2 (n = 17) 2 g/m2 (n = 14) 5 g/m2 (n = 17)
Infusions 68 56 68
Gender (F/M) 5/12 7/7 13/4
SR/IR 13/4 13/1 –/17
Age 6.17 (2.94) 3.78 (3.06) 8.23 (5.25)
Immunophenotype Pre B-ALL (17) Pre B-ALL (13)
T-ALL (1)
Pre-B ALL (16)
T-ALL (1)

SR: Standard risk, IR: Intermediate risk.